177Lu PSMA I&T solution for injection

DRUG2 trials

Sponsors

UZ Leuven, Norwegian University Of Science And Technolology

Conditions

Oligoprogressive metastatic castration-refractory prostate cancerRecurrent grade 3 and grade 4 glioma

Phase 2

68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma

Not yet recruitingCTIS2024-518495-31-00

Norwegian University Of Science And TechnolologyRecurrent grade 3 and grade 4 glioma

Target: 10Updated: 2025-02-11

Phase 3

Metastasis-directed therapy in oligoprogressive castration-refractory prostate cancer: a randomized phase 3 trial

RecruitingCTIS2022-502254-13-00

UZ LeuvenOligoprogressive metastatic castration-refractory prostate cancer

Start: 2023-12-18Target: 246Updated: 2025-07-18